Combatting Carbapenem-Resistant Enterobacteriaceae Bloodstream Infections in Neutropenic Pediatric Hematology Patients: A Comprehensive Analysis

Combatting Carbapenem-Resistant Enterobacteriaceae Bloodstream Infections in Neutropenic Pediatric Hematology Patients: A Comprehensive Analysis

2024.02.29
In July 2023, a  study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal——Antimicrobial Resistance and Infection Control. The title of the study is "High risk of bloodstream infection of carbapenem-resistant enterobacteriaceae carriers in neutropenic children with hematological diseases". The analysis underscores the critical threat posed by carbapenem-resistant Enterobacteriaceae (CRE) bloodstream infections (BSIs) in neutropenic pediatric hematology patients.
Acinetobacter spp. Bloodstream Infection in Hematological Patients: A 10-Year Single-Center Study 

Acinetobacter spp. Bloodstream Infection in Hematological Patients: A 10-Year Single-Center Study 

2024.02.28
In November 2023, a  study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal ——BMC Infectious Diseases. The title of the study is "Acinetobacter spp. Bloodstream Infection in Hematological Patients: A 10-Year Single-Center Study". This comprehensive study sheds light on the significant burden of Acinetobacter spp. BSI in hematological patients, emphasizing the complexity of treating these infections in a population at high risk of adverse outcomes.
IDweek2023 | A Comprehensive Examination of the Influence of Vaccines on Antimicrobial Resistance and Health Burden

IDweek2023 | A Comprehensive Examination of the Influence of Vaccines on Antimicrobial Resistance and Health Burden

2023.10.26
IDweek2023 A Comprehensive Examination of the Influence of Vaccines on Antimicrobial Resistance and Health Burden In a groundbreaking modeling analysis, a consortium of organizations, including the World Health Organization, international vaccine institutes, and the esteemed London School of Hygiene and Tropical Medicine, embarked on an ambitious journey to evaluate the profound impact of vaccines on health burden, antibiotic use, and economic implications. This study employed a pan-pathogen approach to inform the development and prioritization of vaccines, employing a rigorous methodology and aligned assumptions. Furthermore, by joining forces with the Global Burden of Disease Study, this investigation was able to harness granular data to dissect the intricacies of the health burden imposed by antimicrobial resistance (AMR).